Table 2.
The antimicrobial effects of L. angustifolia essential oil against 14 test pathogens.
| Microorganism | Reference strain no. | MIC* |
|---|---|---|
| Methicillin-resistant Staphylococcus aureus (MRSA) | ATCC 43300 | 2.00 |
| Methicillin-resistant Staphylococcus aureus | Clinical strain | 2.00 |
| Methicillin-gentamicin resistant Staphylococcus aureus (MGRSA) | ATCC 33592 | 2.00 |
| Staphylococcus aureus | ATCC 6538 | 2.00 |
| Staphylococcus aureus | Clinical strain | 2.00 |
| Staphylococcus epidermidis | ATCC 2223 | 2.00 |
| Staphylococcus epidermidis | Clinical strain | 2.00 |
| Vancomycin-resistant Enterococcus faecalis | ATCC 51299 | 2.00 |
| Enterococcus faecalis | Clinical strain | 2.00 |
| Klebsiella pneumoniae | ATCC 13883 | 1.50 |
| Pseudomonas aeruginosa | ATCC 27853 | 2.00 |
| Cryptococcus neoformans | ATCC 11093 | 2.00 |
| Candida tropicalis | ATCC 201380 | 0.75 |
| Candida albicans | ATCC 10231 | 3.00 |
| Ciprofloxacin | Positive control | 0.20 × 10−3 to 0.60 × 10−3 |
| Amphotericin B | Positive control | 0.60 × 10−3 |
*MIC given in mg/mL.